Family history in patients with end-stage renal disease on hemodialysis in Tripoli, Libya

被引:1
作者
Elamouri, Jamila [1 ]
机构
[1] Tripoli Cent Hosp, Med Dept, Nephrol Unit, Tripoli, Libya
来源
IBNOSINA JOURNAL OF MEDICINE AND BIOMEDICAL SCIENCES | 2021年 / 13卷 / 01期
关键词
ESRD End-Stage Renal Disease; DM Diabetes Millets; HTN Hypertension; APCKD AdultPolycystic Kidney Disease; VUR Vasico-Ureteric Reflux; DIABETIC KIDNEY-DISEASE; RISK-FACTORS; EPIDEMIOLOGY; GOVERNORATE;
D O I
10.4103/ijmbs.ijmbs_5_21
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: End-Stage Renal Disease (ESRD) is a global health problem due to increasing its burden worldwide. High-risk groups include family members of patients with ESRD. Objectives: To determine the prevalence of ESRD among dialysis patients' families. At Al-Shat kidney dialysis Center, Tripoli, Libya. So can conclude that the ESRD patient is an index case for a high- risk population. Methods: All patients' data were collected through direct interview with the patients for 15- 20 minutes and by reviewing patients' charts. Patients who decline consent to participate and those with mental or speech disability were excluded, and patients on peritoneal dialysis. The study carried at Al-Shat kidney dialysis centre, Tripoli, Libya. In January 2019. Results: 261 patients were interviewed, mean age 51.8 years (+/- 15), nearly half (48.7%) of them, between 45 to 65 years and 31.8% younger than 45 years. 56.3% were men, and 43.7% were women. The leading causes of ESRD in these patients were DM, HTN, congenital abnormalities (APCKD/VUR) and GN (35.2%, 22.2%, 10%, 8%). Positive family history of ESRD was reportedby 26.8% of these patients. From them, 47% (33/70) were between 45 to 65 years ofage. 58.6% were male (41/70). 34.3% have diabetic, 20% have HTN, 13%have congenital abnormalities, and 7% GN. Conclusions: Positive familyhistory of ESRD was high in dialysis patients. These patients can be used as anindex case to identify high- risk population.
引用
收藏
页码:14 / 19
页数:6
相关论文
共 35 条
  • [1] Quality of diabetes care in a university health center in Lebanon
    Akel, M
    Hamadeh, G
    [J]. INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 1999, 11 (06) : 517 - 521
  • [2] Al-Rohani Muhamed, 2003, Saudi J Kidney Dis Transpl, V14, P80
  • [3] Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya
    Alashek, Wiam A.
    McIntyre, Christopher W.
    Taal, Maarten W.
    [J]. BMC NEPHROLOGY, 2012, 13
  • [4] [Anonymous], 2015, SAUDI J KIDNEY DIS T, V26, P839
  • [5] Bethesda MD, 2011, USRDS ANN DAT REP AT
  • [6] El Minshawy O, 2011, SAUDI J KIDNEY DIS T, V22, P1048
  • [7] El-Amin A, 2009, ARAB J NEPHROL TRANS, V3, P31
  • [8] Diabetics on hemodialysis in El-Minia Governorate, Upper Egypt: five-year study
    El-Minshawy, Osama
    Kamel, Emad G.
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2011, 43 (02) : 507 - 512
  • [9] END-STAGE RENAL-DISEASE AND RENAL REPLACEMENT THERAPY IN KUWAIT - EPIDEMIOLOGIC PROFILE OVER THE PAST 4 1/2 YEARS
    ELRESHAID, K
    JOHNY, KV
    SUGATHAN, TN
    HAKIM, A
    GEORGOUS, M
    NAMPOORY, MRN
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (05) : 532 - 538
  • [10] Freedman BI, 1997, J AM SOC NEPHROL, V8, P1942